Isolation and characterization of extracellular vesicles for clinical applications in cancer - time for standardization?

被引:27
|
作者
Salmond, Nikki [1 ]
Williams, Karla C. [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada
来源
NANOSCALE ADVANCES | 2021年 / 3卷 / 07期
基金
加拿大自然科学与工程研究理事会;
关键词
Cell-cell communications - Clinical application - Extracellular space - Functional capacity - Isolation and characterization - Physiological roles - Protein concentrations - Therapeutic delivery;
D O I
10.1039/d0na00676a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Extracellular vesicles (EVs) are nanometer sized lipid enclosed particles released by all cell types into the extracellular space and biological fluids in vivo, and into cell culture media in vitro. An important physiological role of EVs is cell-cell communication. EVs interact with, and deliver, their contents to recipient cells in a functional capacity; this makes EVs desirable vehicles for the delivery of therapeutic cargoes. In addition, as EVs contain proteins, lipids, glycans, and nucleic acids that reflect their cell of origin, their potential utility in disease diagnosis and prognostication is of great interest. The number of published studies analyzing EVs and their contents in the pre-clinical and clinical setting is rapidly expanding. However, there is little standardization as to what techniques should be used to isolate, purify and characterize EVs. Here we provide a comprehensive literature review encompassing the use of EVs as diagnostic and prognostic biomarkers in cancer. We also detail their use as therapeutic delivery vehicles to treat cancer in pre-clinical and clinical settings and assess the EV isolation and characterization strategies currently being employed. Our report details diverse isolation strategies which are often dependent upon multiple factors such as biofluid type, sample volume, and desired purity of EVs. As isolation strategies vary greatly between studies, thorough EV characterization would be of great importance. However, to date, EV characterization in pre-clinical and clinical studies is not consistently or routinely adhered to. Standardization of EV characterization so that all studies image EVs, quantitate protein concentration, identify the presence of EV protein markers and contaminants, and measure EV particle size and concentration is suggested. Additionally, the use of RNase, DNase and protease EV membrane protection control experiments is recommended to ensure that the cargo being investigated is truly EV associated. Overall, diverse methodology for EV isolation is advantageous as it can support different sample types and volumes. Nevertheless, EV characterization is crucial and should be performed in a rigorous manor.
引用
收藏
页码:1830 / 1852
页数:23
相关论文
共 50 条
  • [21] Isolation and characterization of extracellular vesicles in saliva of children with asthma
    Comfort, Nicole
    Bloomquist, Tessa R.
    Shephard, Alex P.
    Petty, Carter R.
    Cunningham, Amparito
    Hauptman, Marissa
    Phipatanakul, Wanda
    Baccarelli, Andrea
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2021, 2 (01): : 29 - 48
  • [22] Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles
    Kim, Gun-Hwa
    Choi, Chi W.
    Park, Edmond C.
    Lee, Sang-Yeop
    Kim, Seung Ii
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (07) : 719 - 731
  • [23] Editorial: Novel clinical applications of extracellular vesicles
    Saenz-Cuesta, Matas
    Mittelbrunn, Maria
    Otaegui, David
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 2
  • [24] Clinical applications and challenges in the field of extracellular vesicles
    Nieuwland, Rienk
    Enciso-Martinez, Agustin
    Bracht, Jillian W. P.
    MEDIZINISCHE GENETIK, 2023, 35 (04) : 251 - 258
  • [25] Isolation and characterization of extracellular vesicles (EVs) from ovarian cancer ascites - a feasibility study
    Reinhardt, N.
    Lettau, M.
    Hugendieck, G.
    Neumann, S.
    Rogmans, C.
    Weimer, J. P.
    Floerkemeier, I
    Arnold, N.
    Arnold, P.
    Janssen, O.
    Maass, N.
    Bauerschlag, D. O.
    Hedemann, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E148 - E148
  • [26] Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
    Kosaka, Nobuyoshi
    Kogure, Akiko
    Yamamoto, Tomofumi
    Urabe, Fumihiko
    Usuba, Wataru
    Prieto-Vila, Marta
    Ochiya, Takahiro
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (3): : 1 - 9
  • [27] Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
    Jiangdong Qiu
    Gang Yang
    Mengyu Feng
    Suli Zheng
    Zhe Cao
    Lei You
    Lianfang Zheng
    Taiping Zhang
    Yupei Zhao
    Molecular Cancer, 17
  • [28] Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
    Qiu, Jiangdong
    Yang, Gang
    Feng, Mengyu
    Zheng, Suli
    Cao, Zhe
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    MOLECULAR CANCER, 2018, 17
  • [29] Extracellular vesicles in the breast cancer brain metastasis: physiological functions and clinical applications
    Sakamoto, Yuima
    Ochiya, Takahiro
    Yoshioka, Yusuke
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [30] Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
    Nobuyoshi Kosaka
    Akiko Kogure
    Tomofumi Yamamoto
    Fumihiko Urabe
    Wataru Usuba
    Marta Prieto-Vila
    Takahiro Ochiya
    Experimental & Molecular Medicine, 2019, 51 : 1 - 9